4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000950170-25-017031
Director bought 550,000 shares at $18.00 ($9,900,000)
- Director acquired 3,154,959 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. Director | 2025-02-10 | Conversion | +3,154,959 | 3,154,959 | I | ||
| Thompson Peter A. Director | 2025-02-10 | Purchase | +550,000 | $18.00 | $9,900,000 | 3,704,959 | I |
| Derivatives | |||||||
| Thompson Peter A. Director | 2025-02-10 | Conversion · Series B convertible preferred stock | −2,560,951 | 0 | I | ||
| Thompson Peter A. Director | 2025-02-10 | Conversion · Series C convertible preferred stock | −2,048,760 | 0 | I | ||
| Open-market purchases · 550,000 sh · avg $18.00 · $9,900,000 | |||||||
Loading xslF345X05/ownership.xml…